Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1950 1
1951 3
1952 4
1953 3
1954 4
1955 1
1956 3
1957 6
1958 2
1959 7
1960 9
1961 11
1962 18
1963 18
1964 14
1965 19
1966 7
1967 12
1968 8
1969 12
1970 10
1971 15
1972 13
1973 21
1974 18
1975 13
1976 12
1977 15
1978 12
1979 13
1980 16
1981 19
1982 21
1983 26
1984 21
1985 26
1986 21
1987 25
1988 25
1989 33
1990 28
1991 29
1992 26
1993 35
1994 37
1995 27
1996 42
1997 50
1998 64
1999 49
2000 62
2001 64
2002 74
2003 59
2004 63
2005 77
2006 100
2007 82
2008 105
2009 132
2010 147
2011 161
2012 180
2013 200
2014 230
2015 235
2016 257
2017 248
2018 265
2019 277
2020 304
2021 348
2022 381
2023 362
2024 329
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,221 results

Results by year

Filters applied: . Clear all
Page 1
Vitek() 2 MICs as first-line phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa.
Sieswerda E, Bosch T, Lankelma JM, Schouls LM, Dijk KV. Sieswerda E, et al. Future Microbiol. 2021 Jul;16:777-781. doi: 10.2217/fmb-2020-0024. Epub 2021 Jul 7. Future Microbiol. 2021. PMID: 34229445
Aim: To define sensitivity and specificity of Vitek() 2 MICs as phenotypic screening method for carbapenemase-producing Pseudomonas aeruginosa. ...Conclusion: Vitek() 2 MIC> epidemiological cut-off values seem sensitive and specific as a phenotypic screening stra …
Aim: To define sensitivity and specificity of Vitek() 2 MICs as phenotypic screening method for carbapenemase-producing Pseudomonas a …
Using Vitek MS v3.0 To Identify Nontuberculous Mycobacteria in Liquid Media in a Clinical Microbiology Laboratory.
Luo L, Liang L, Zhang R, Chen W, Yu F, Zhao Y, Yue J. Luo L, et al. Microbiol Spectr. 2022 Dec 21;10(6):e0201822. doi: 10.1128/spectrum.02018-22. Epub 2022 Oct 26. Microbiol Spectr. 2022. PMID: 36287015 Free PMC article.
Vitek MS v3.0 showed a promising rate for identification NTM isolates in positive liquid cultures. ...Vitek MS v3.0 represented a valuable technique for NTM identification from positive liquid cultures....
Vitek MS v3.0 showed a promising rate for identification NTM isolates in positive liquid cultures. ...Vitek MS v3.0 represente …
Vitek() MS v3.0 System in the Identification of Filamentous Fungi.
Pinheiro D, Monteiro C, Faria MA, Pinto E. Pinheiro D, et al. Mycopathologia. 2019 Oct;184(5):645-651. doi: 10.1007/s11046-019-00377-0. Epub 2019 Sep 10. Mycopathologia. 2019. PMID: 31506883
However, it has less used for molds identification. The aim of this study was to evaluate Vitek() MS (a MALDI-TOF MS system) ability to identify molds and differentiate species within a complex. A collection of 90 filamentous fungi, 70 clinical and 20 environmental isolate …
However, it has less used for molds identification. The aim of this study was to evaluate Vitek() MS (a MALDI-TOF MS system) ability …
Clinical application of Vitek-derived minimum inhibitory concentration values: Proof of concept study.
Lowman W. Lowman W. S Afr J Infect Dis. 2023 Mar 31;38(1):498. doi: 10.4102/sajid.v38i1.498. eCollection 2023. S Afr J Infect Dis. 2023. PMID: 37063451 Free PMC article.
OBJECTIVES: This proof of concept study aims to demonstrate the clinical utility and application of Vitek()-derived MIC values through categorisation of clinical isolates as wild type. METHOD: A random selection of clinically relevant Gram negative isolates routinely teste …
OBJECTIVES: This proof of concept study aims to demonstrate the clinical utility and application of Vitek()-derived MIC values throug …
A side-by-side comparison of the new VITEK MS PRIME and the MALDI Biotyper sirius in the clinical microbiology laboratory.
Thelen P, Graeber S, Schmidt E, Hamprecht A. Thelen P, et al. Eur J Clin Microbiol Infect Dis. 2023 Nov;42(11):1355-1363. doi: 10.1007/s10096-023-04666-x. Epub 2023 Oct 5. Eur J Clin Microbiol Infect Dis. 2023. PMID: 37794128 Free PMC article.
Overall, 618 bacterial isolates from a tertiary hospital's laboratory were processed using the VITEK MS PRIME (bioMerieux) and the MALDI Biotyper sirius (Bruker Daltonics) and their corresponding databases VITEK IVD Database 3.2 and MBT reference library 12. ...In t …
Overall, 618 bacterial isolates from a tertiary hospital's laboratory were processed using the VITEK MS PRIME (bioMerieux) and the MA …
Methodology Establishment and Application of VITEK Mass Spectrometry to Detect Carbapenemase-Producing Klebsiella pneumoniae.
Lin H, Hu Z, Wu J, Lu Y, Chen J, Wu W. Lin H, et al. Front Cell Infect Microbiol. 2022 Feb 11;12:761328. doi: 10.3389/fcimb.2022.761328. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 35223536 Free PMC article.
The ability of VITEK mass spectrometry (MS) in detection of bacterial resistance is currently under exploration and evaluation. ...Thus, VITEK MS can be used for rapid detection of CPKP, especially for some common types of CPKP. ...
The ability of VITEK mass spectrometry (MS) in detection of bacterial resistance is currently under exploration and evaluation. ...Th …
A side-by-side comparison of the performance and time-and-motion data of VITEK MS.
Bardelli M, Padovani M, Fiorentini S, Caruso A, Yamamura D, Gaskin M, Jissam A, González-López JJ, Larrosa MN, Pumarola T, Lassus A, Louis B, Capron N. Bardelli M, et al. Eur J Clin Microbiol Infect Dis. 2022 Aug;41(8):1115-1125. doi: 10.1007/s10096-022-04472-x. Epub 2022 Jul 16. Eur J Clin Microbiol Infect Dis. 2022. PMID: 35841452
VITEK MS PRIME and VITEK MS were concordant to the species and genus level for 1354/1413 (95.8%) and to the species level for 1341/1413 (94.9%). ...A time-and-motion study showed that the use of VITEK MS PRIME was associated with significant time saving. V …
VITEK MS PRIME and VITEK MS were concordant to the species and genus level for 1354/1413 (95.8%) and to the species level for …
Correlation of Vitek 2 and Agar dilution for levofloxacin susceptibility testing and clinical outcomes of Enterobacterales bacteremia with 2019 CLSI breakpoints.
Huang HY, Chang YT, Lu PL, Yang TY, Wang YL, Chen TC, Wu JH, Lin SY. Huang HY, et al. Diagn Microbiol Infect Dis. 2022 Dec;104(4):115799. doi: 10.1016/j.diagmicrobio.2022.115799. Epub 2022 Aug 25. Diagn Microbiol Infect Dis. 2022. PMID: 36215940

Higher levofloxacin MICs (1 or 2 mug/mL) determined using Vitek 2 or AD predicted early clinical failure (P < 0.001 for Vitek 2 and P = 0.001 for AD). ...Although discrepant results were obtained, the MICs measured by Vitek 2 could still predict treatment

…

Higher levofloxacin MICs (1 or 2 mug/mL) determined using Vitek 2 or AD predicted early clinical failure (P < 0.001 for Vitek

…
Combining VITEK() 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility.
Lellouche J, Schwartz D, Elmalech N, Ben Dalak MA, Temkin E, Paul M, Geffen Y, Yahav D, Eliakim-Raz N, Durante-Mangoni E, Iossa D, Bernardo M, Daikos GL, Skiada A, Pantazatou A, Antoniadou A, Mouton JW, Carmeli Y; AIDA study group. Lellouche J, et al. Clin Microbiol Infect. 2019 Jun;25(6):711-716. doi: 10.1016/j.cmi.2018.09.014. Epub 2018 Oct 4. Clin Microbiol Infect. 2019. PMID: 30291971 Free article.
BMD is not easily incorporated into the routine work of clinical laboratories, and usually this test is incorporated serially, resulting in delayed susceptibility reporting. We tested a strategy of combining VITEK() 2 with a 2 mug/mL colistin agar dilution (VITEK() …
BMD is not easily incorporated into the routine work of clinical laboratories, and usually this test is incorporated serially, resulting in …
Retrospective analysis of Vitek()2 performance compared to manual broth micro-dilution for colistin susceptibility testing of Acinetobacter baumanniicomplex isolates in South Africa.
Fadana V, Thomas T, von Knorring N. Fadana V, et al. Afr J Lab Med. 2022 Feb 28;11(1):1597. doi: 10.4102/ajlm.v11i1.1597. eCollection 2022. Afr J Lab Med. 2022. PMID: 35282395 Free PMC article.
Vitek()2 yielded a categorical agreement of 89%, an essential agreement of 56%, a major error rate of 8% and a very major error rate of 55%. The Vitek()2 is not an alternative to mBMD for colistin susceptibility testing....
Vitek()2 yielded a categorical agreement of 89%, an essential agreement of 56%, a major error rate of 8% and a very major error rate …
5,221 results